Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00125086 · ClinicalTrials.gov registry record · NA
Platelets for Acute Wound Healing
A NA study, sponsored by Medtronic.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT00125086: Completed NA study, sponsored by Medtronic.
NCT00125086 is a NA study that has completed, run by Medtronic. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00125086, a NA study, has completed, sponsored by Medtronic.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
This study will examine whether platelet gel positively affects wound healing. Platelet gel will be used to treat punch biopsy wounds and the results will be compared to results from wounds treated with a control treatment.
Interventions
- DEVICE autologous platelet gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2005-07 |
| Est. Completion | 2006-02 |
| Phase | NA |
What the finished NCT00125086 record still lists
NCT00125086 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which autologous platelet gel is the first listed.
NCT00125086 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00125086 about?
NCT00125086 is a clinical study titled "Platelets for Acute Wound Healing". This study will examine whether platelet gel positively affects wound healing. Platelet gel will be used to treat punch biopsy wounds and the results will be compared to results from wounds treated with a control treatment.
What is the current status of trial NCT00125086?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2005-07. Estimated completion is 2006-02.
What interventions are being tested in trial NCT00125086?
The interventions under investigation include: autologous platelet gel (DEVICE).
Who is sponsoring clinical trial NCT00125086?
This trial is sponsored by Medtronic, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00125086's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia